Skip to Main Content

Advertisement

Skip Nav Destination

Abstract S6-04: Fulvestrant 500 mg versus anastrozole as first-line treatment for advanced breast cancer: Overall survival from the Phase II ‘FIRST’ study

Cancer Res (2015) 75 (9_Supplement): S6-04.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Amit Agrawal
  • John F.R. Robertson
  • Kwok L. Cheung
  • Eleanor Gutteridge
  • Ian O. Ellis
  • Robert I. Nicholson
  • Julia M.W. Gee
International Journal of Cancer (2016) 138 (1): 146.
  • Sabrina Witherby
  • Tina Rizack
  • Bachir J. Sakr
  • Robert D. Legare
  • William M. Sikov
Seminars in Radiation Oncology (2016) 26 (1): 59.
  • Daniel Berger
  • Salman Waheed
  • Yacob Fattout
  • Rasa Kazlauskaite
  • Lydia Usha
Clinical Breast Cancer (2016) 16 (1): e11.
  • Cynthia X. Ma
  • Tomás Reinert
  • Izabela Chmielewska
  • Matthew J. Ellis
Nature Reviews Cancer (2015) 15 (5): 261.
  • Suzanne E Wardell
  • Erik R Nelson
  • Christina A Chao
  • Holly M Alley
  • Donald P McDonnell
Endocrine-Related Cancer (2015) 22 (5): 713.
  • Sara A Hurvitz
  • Fabrice Andre
  • Zefei Jiang
  • Zhimin Shao
  • Max S Mano
  • Silvia P Neciosup
  • Ling-Min Tseng
  • Qingyuan Zhang
  • Kunwei Shen
  • Donggeng Liu
  • Lydia M Dreosti
  • Howard A Burris
  • Masakazu Toi
  • Marc E Buyse
  • David Cabaribere
  • Mary-Ann Lindsay
  • Shantha Rao
  • Lida Bubuteishvili Pacaud
  • Tetiana Taran
  • Dennis Slamon
The Lancet Oncology (2015) 16 (7): 816.
  • Adrienne G. Waks
  • James Lennon
  • Budhi S. Yadav
  • Helena Hwang
  • Marcela dSchapirael Carmen
  • Nicole B. Johnson
  • Kerry Reynolds
  • Lidia Schapira
  • Paul B. Gilman
  • Beth Overmoyer
Seminars in Oncology (2015) 42 (4): e81.
  • Christopher D. Hart
  • Ilenia Migliaccio
  • Luca Malorni
  • Cristina Guarducci
  • Laura Biganzoli
  • Angelo Di Leo
Nature Reviews Clinical Oncology (2015) 12 (9): 541.
Close Modal

or Create an Account

Close Modal
Close Modal